Updates

IGL/SE/2026-27/24 17th July, 2026 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai- 400 051 Scrip Code: 500201 Symbol: INDIAGLYCO Dear Sirs, Sub: Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”): Update on hearing before NCLT, Allahabad Bench at Prayagraj This is in continuation of our earlier intimation dated 3rd July 2026 bearing no: IGL/SE/2026- 27/22 in relation to the Scheme of Arrangement amongst India Glycols Limited (“Demerged Company”/ “the Company”), Ennature Bio Pharma Limited (“Resulting Company 1” / “EBL”) and IGL Spirits Limited (“Resulting Company 2”/ “ISL”) and their respective shareholders, involving demerger of Bio Pharma Undertaking into EBL and Spirits and Biofuel Undertaking into ISL (“Scheme”), pursuant to the provisions of Section 230 to 232 of the Companies Act, 2013 and the rules framed thereunder. In this regard, we wish to inform that the Hon’ble National Company Law Tribunal, Allahabad Bench at Prayagraj (“Hon’ble NCLT”) has today, i.e., on 17th July 2026, pronounced its Order, sanctioning the aforesaid Scheme (“Order”). The copy of the Order will be submitted once the same is uploaded on the website of the Hon’ble NCLT. Kindly take the above information on record. Thanking you, Yours faithfully, For India Glycols Limited Ankur Jain Head (Legal) & Company Secretary